甘氨酸脱糖酶通过干扰素刺激基因因子3-中介途径调节癌进展
Thi Tuyet Mai Pham1, Mikyung Kim1, Thuy Quynh Nhu Nguyen1
1Department of Biochemistry, School of Medicine, Keimyung University, Daegu 42601, Republic of Korea.
International journal of biological sciences
|January 9, 2025
概括
甘氨酸脱碳酶 (GLDC) 通过影响核酸合成和细胞生长,影响细胞癌 (RCC) 的进展. 准GLDC可能为治疗这种代谢性疾病提供了一个新的策略.
科学领域:
- 在瘤学瘤学.
- 代谢途径 代谢途径
- 癌症生物学 癌症生物学
背景情况:
- 细胞癌 (RCC) 表现出代谢失调.
- 甘氨酸脱碳酶 (GLDC) 是一种线粒体酶,对于核酸生物合成至关重要.
- 需要阐明GLDC在RCC发病过程中的作用.
研究的目的:
- 研究GLDC在细胞癌 (RCC) 发展中的作用.
- 探索潜在的分子机制,包括代谢和信号通路.
主要方法:
- 在体外和体内研究涉及GLDC敲击和过度表达.
- 核酸合成,活性氧物种 (ROS) 生成和细胞增殖的评估.
- 对干扰素刺激基因因子3 (ISGF3) 途径的分析,包括IRF9和STAT2表达.
- 对化学疗法反应的DNA损伤和细胞循环效应的评估.
主要成果:
- GLDC耗尽减少了核酸合成,增加了ROS,并抑制了RCC的进展.
- GLDC通过ISGF3通路调节RCC细胞增殖和瘤生长.
- GLDC调制影响了IRF9和STAT2表达,影响了细胞增殖.
- GLDC缺乏症增强了化疗诱导的DNA损伤和线粒体灾难.
结论:
- GLDC在通过ISGF3信号通路调节RCC进展方面发挥着重要作用.
- GLDC对核酸合成,扩散和DNA损伤的影响凸显了其作为治疗点的潜力.
- 针对GLDC为新型RCC治疗提供了一个有前途的战略.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
01:16TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
01:09GPCRs Regulate Adenylyl Cylase Activity
5.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.3K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K